Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Prepaid Assets (2017 - 2025)

Historic Prepaid Assets for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to $46.9 million.

  • Crinetics Pharmaceuticals' Prepaid Assets rose 21447.15% to $46.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.9 million, marking a year-over-year increase of 21447.15%. This contributed to the annual value of $23.6 million for FY2024, which is 5160.92% up from last year.
  • According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Prepaid Assets is $46.9 million, which was up 21447.15% from $20.4 million recorded in Q2 2025.
  • Crinetics Pharmaceuticals' Prepaid Assets' 5-year high stood at $46.9 million during Q3 2025, with a 5-year trough of $7.1 million in Q1 2021.
  • Over the past 5 years, Crinetics Pharmaceuticals' median Prepaid Assets value was $11.8 million (recorded in 2024), while the average stood at $15.3 million.
  • As far as peak fluctuations go, Crinetics Pharmaceuticals' Prepaid Assets plummeted by 4170.41% in 2024, and later skyrocketed by 21447.15% in 2025.
  • Crinetics Pharmaceuticals' Prepaid Assets (Quarter) stood at $11.0 million in 2021, then decreased by 2.31% to $10.8 million in 2022, then surged by 44.98% to $15.6 million in 2023, then skyrocketed by 51.61% to $23.6 million in 2024, then soared by 98.39% to $46.9 million in 2025.
  • Its last three reported values are $46.9 million in Q3 2025, $20.4 million for Q2 2025, and $16.4 million during Q1 2025.